Two Sigma Securities’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-2,177
Closed -$535K 3475
2022
Q3
$535K Buy
+2,177
New +$588K 0.02% 1054
2020
Q4
Sell
-1,154
Closed -$319K 2038
2020
Q3
$320K Buy
+1,154
New +$332K 0.01% 825
2019
Q3
Sell
-1,126
Closed -$243K 2570
2019
Q2
$293K Buy
+1,126
New +$299K ﹤0.01% 1468
2018
Q3
Sell
-513
Closed -$210K 3141
2018
Q2
$210K Sell
513
-883
-63% -$320K ﹤0.01% 2331
2018
Q1
$406K Sell
1,396
-324
-19% -$82.1K ﹤0.01% 1805
2017
Q4
$322K Buy
+1,720
New +$321K 0.01% 959

Other funds holding ABMD

Two Sigma Securities's ABMD Position: Q4 2022 in Review

Two Sigma Securities sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 2,177 shares — an estimated $535K sold.

Two Sigma Securities first reported a position in ABMD in Q4 2017 and held it in 6 quarters. The position peaked at $535K in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Two Sigma Securities reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Two Sigma Securities sold 2,177 Abiomed Inc shares in Q4 2022, an estimated $535K.
  • Two Sigma Securities first reported a position in Abiomed Inc in Q4 2017 and held it in 6 quarters.
  • Two Sigma Securities's Abiomed Inc position peaked at $535K in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Two Sigma Securities's 13F filing for Q4 2022, filed 14 Feb 2023.